Journal of Cancer Treatment and Research

Volume 7, Issue 2, June 2019

  • Anastomosis Is Possible with an Acceptable Low Rate of Complications Compared to a Diverting Stoma in Surgery for Ovarian Cancer

    Vibe Munk Bertelsen, Gitte Ørtoft Lykkegård, Lone Kjeld Petersen

    Issue: Volume 7, Issue 2, June 2019
    Pages: 28-32
    Received: 10 March 2019
    Accepted: 25 April 2019
    Published: 5 June 2019
    Abstract: Radical surgery for advanced stage of ovarian cancer may lead to bowel resection and consequently either an anastomosis or a diverting stoma. This study investigates whether it is possible to find selection criteria which predict benefits from an anastomosis compared to a diverting stoma, in order to prevent complications and leakage. Consecutive p... Show More
  • MicroRNA95 May Be Involved in Oligometastatic Prostate Cancer

    Carlos Ferrer Albiach, Enrique Ochoa Aranda, Alfonso Gomez Iturriaga-Piña, Amalia Sotoca Ruiz, Fernando López Campos, Mariano Porras Martinez, Raquel García Gómez, Manel Algara Lopez, Virginia Ramos Fernandez, Antonio Conde Moreno, Susana Ors, Esther Flores, Francisco Garcia Piñón

    Issue: Volume 7, Issue 2, June 2019
    Pages: 33-40
    Received: 17 June 2019
    Accepted: 19 July 2019
    Published: 6 August 2019
    Abstract: The oligometastatic status in the prostate is a new entity of metastatic patients in which their treatment allows to improve survival over standard treatments. There are several theories about their biological origin, one of them being alterations in the expression of miRNas This. was a retrospective multicentre study undertaken in patients with ol... Show More
  • Effect of Magnesium Supplementation to Prevent Nephrotoxicity on the Antitumor Activity of Cisplatin

    Megumi Yasuda, Shuichi Kishimoto, Rika Ebara, Manabu Amano, Shoji Fukushima

    Issue: Volume 7, Issue 2, June 2019
    Pages: 41-46
    Received: 5 August 2019
    Accepted: 24 August 2019
    Published: 9 September 2019
    Abstract: Background: Cisplatin (CDDP) is one of the most widely used anticancer drugs, but CDDP often leads to nephrotoxicity, which limits its clinical effectiveness. Magnesium (Mg) supplementation is recommended for the avoidance of CDDP-induced nephrotoxicity. However, there is a concern that exposing cancer cells to Mg may suppress the antitumor effect ... Show More